nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Dizziness—Progesterone—uterine cancer	0.00145	0.00145	CcSEcCtD
Meropenem—Immune system disorder—Etoposide—uterine cancer	0.00142	0.00142	CcSEcCtD
Meropenem—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00142	CcSEcCtD
Meropenem—Hepatic failure—Epirubicin—uterine cancer	0.00142	0.00142	CcSEcCtD
Meropenem—Chills—Etoposide—uterine cancer	0.00141	0.00141	CcSEcCtD
Meropenem—Sepsis—Doxorubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Meropenem—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.0014	CcSEcCtD
Meropenem—Vomiting—Progesterone—uterine cancer	0.00139	0.00139	CcSEcCtD
Meropenem—Rash—Progesterone—uterine cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Dermatitis—Progesterone—uterine cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Phlebitis—Doxorubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Meropenem—Headache—Progesterone—uterine cancer	0.00137	0.00137	CcSEcCtD
Meropenem—Thrombophlebitis—Doxorubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Decreased appetite—Dactinomycin—uterine cancer	0.00134	0.00134	CcSEcCtD
Meropenem—Dysgeusia—Etoposide—uterine cancer	0.00134	0.00134	CcSEcCtD
Meropenem—Back pain—Etoposide—uterine cancer	0.00133	0.00133	CcSEcCtD
Meropenem—Pain—Dactinomycin—uterine cancer	0.00132	0.00132	CcSEcCtD
Meropenem—Hepatic failure—Doxorubicin—uterine cancer	0.00131	0.00131	CcSEcCtD
Meropenem—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00131	CcSEcCtD
Meropenem—Hypoglycaemia—Epirubicin—uterine cancer	0.00131	0.00131	CcSEcCtD
Meropenem—Cardiac failure—Epirubicin—uterine cancer	0.00131	0.00131	CcSEcCtD
Meropenem—Nausea—Progesterone—uterine cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Meropenem—Feeling abnormal—Dactinomycin—uterine cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Anaemia—Etoposide—uterine cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00125	CcSEcCtD
Meropenem—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00125	CcSEcCtD
Meropenem—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00124	CcSEcCtD
Meropenem—Malaise—Etoposide—uterine cancer	0.00124	0.00124	CcSEcCtD
Meropenem—Leukopenia—Etoposide—uterine cancer	0.00123	0.00123	CcSEcCtD
Meropenem—Abdominal pain—Dactinomycin—uterine cancer	0.00122	0.00122	CcSEcCtD
Meropenem—Body temperature increased—Dactinomycin—uterine cancer	0.00122	0.00122	CcSEcCtD
Meropenem—Cardiac arrest—Epirubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Meropenem—Hypoglycaemia—Doxorubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Meropenem—Cardiac failure—Doxorubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Meropenem—Loss of consciousness—Etoposide—uterine cancer	0.00121	0.00121	CcSEcCtD
Meropenem—Cough—Etoposide—uterine cancer	0.0012	0.0012	CcSEcCtD
Meropenem—Blood creatinine increased—Epirubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
Meropenem—Hypertension—Etoposide—uterine cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Chest pain—Etoposide—uterine cancer	0.00117	0.00117	CcSEcCtD
Meropenem—Hypokalaemia—Epirubicin—uterine cancer	0.00116	0.00116	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00116	0.00116	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00115	0.00115	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00115	0.00115	CcSEcCtD
Meropenem—Hypersensitivity—Dactinomycin—uterine cancer	0.00114	0.00114	CcSEcCtD
Meropenem—Confusional state—Etoposide—uterine cancer	0.00113	0.00113	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Meropenem—Cardiac arrest—Doxorubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Meropenem—Anaphylactic shock—Etoposide—uterine cancer	0.00112	0.00112	CcSEcCtD
Meropenem—Infection—Etoposide—uterine cancer	0.00111	0.00111	CcSEcCtD
Meropenem—Abdominal distension—Epirubicin—uterine cancer	0.00111	0.00111	CcSEcCtD
Meropenem—Asthenia—Dactinomycin—uterine cancer	0.00111	0.00111	CcSEcCtD
Meropenem—Blood creatinine increased—Doxorubicin—uterine cancer	0.00111	0.00111	CcSEcCtD
Meropenem—Asthma—Epirubicin—uterine cancer	0.0011	0.0011	CcSEcCtD
Meropenem—Thrombocytopenia—Etoposide—uterine cancer	0.0011	0.0011	CcSEcCtD
Meropenem—Tachycardia—Etoposide—uterine cancer	0.00109	0.00109	CcSEcCtD
Meropenem—Eosinophilia—Epirubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Meropenem—Skin disorder—Etoposide—uterine cancer	0.00109	0.00109	CcSEcCtD
Meropenem—Hyperhidrosis—Etoposide—uterine cancer	0.00108	0.00108	CcSEcCtD
Meropenem—Hypokalaemia—Doxorubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Meropenem—Anorexia—Etoposide—uterine cancer	0.00107	0.00107	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00106	0.00106	CcSEcCtD
Meropenem—Diarrhoea—Dactinomycin—uterine cancer	0.00106	0.00106	CcSEcCtD
Meropenem—Hypotension—Etoposide—uterine cancer	0.00105	0.00105	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Meropenem—Dysuria—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Neutropenia—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Asthma—Doxorubicin—uterine cancer	0.00102	0.00102	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Meropenem—Paraesthesia—Etoposide—uterine cancer	0.001	0.001	CcSEcCtD
Meropenem—Dyspnoea—Etoposide—uterine cancer	0.000998	0.000998	CcSEcCtD
Meropenem—Somnolence—Etoposide—uterine cancer	0.000995	0.000995	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—uterine cancer	0.000989	0.000989	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—uterine cancer	0.000983	0.000983	CcSEcCtD
Meropenem—Infestation—Epirubicin—uterine cancer	0.000983	0.000983	CcSEcCtD
Meropenem—Vomiting—Dactinomycin—uterine cancer	0.000983	0.000983	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000975	0.000975	CcSEcCtD
Meropenem—Rash—Dactinomycin—uterine cancer	0.000975	0.000975	CcSEcCtD
Meropenem—Decreased appetite—Etoposide—uterine cancer	0.000973	0.000973	CcSEcCtD
Meropenem—Renal failure—Epirubicin—uterine cancer	0.000967	0.000967	CcSEcCtD
Meropenem—Gastrointestinal disorder—Etoposide—uterine cancer	0.000966	0.000966	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—uterine cancer	0.000964	0.000964	CcSEcCtD
Meropenem—Jaundice—Epirubicin—uterine cancer	0.000959	0.000959	CcSEcCtD
Meropenem—Constipation—Etoposide—uterine cancer	0.000957	0.000957	CcSEcCtD
Meropenem—Pain—Etoposide—uterine cancer	0.000957	0.000957	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—uterine cancer	0.000954	0.000954	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—uterine cancer	0.000954	0.000954	CcSEcCtD
Meropenem—Sweating—Epirubicin—uterine cancer	0.000943	0.000943	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—uterine cancer	0.00093	0.00093	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—uterine cancer	0.000928	0.000928	CcSEcCtD
Meropenem—Feeling abnormal—Etoposide—uterine cancer	0.000922	0.000922	CcSEcCtD
Meropenem—Nausea—Dactinomycin—uterine cancer	0.000918	0.000918	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—uterine cancer	0.000918	0.000918	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—uterine cancer	0.000915	0.000915	CcSEcCtD
Meropenem—Gastrointestinal pain—Etoposide—uterine cancer	0.000915	0.000915	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—uterine cancer	0.00091	0.00091	CcSEcCtD
Meropenem—Infestation—Doxorubicin—uterine cancer	0.00091	0.00091	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000902	0.000902	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—uterine cancer	0.000899	0.000899	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—uterine cancer	0.000894	0.000894	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000892	0.000892	CcSEcCtD
Meropenem—Urticaria—Etoposide—uterine cancer	0.000889	0.000889	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—uterine cancer	0.000887	0.000887	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—uterine cancer	0.000887	0.000887	CcSEcCtD
Meropenem—Abdominal pain—Etoposide—uterine cancer	0.000885	0.000885	CcSEcCtD
Meropenem—Body temperature increased—Etoposide—uterine cancer	0.000885	0.000885	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—uterine cancer	0.000883	0.000883	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—uterine cancer	0.000883	0.000883	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—uterine cancer	0.000876	0.000876	CcSEcCtD
Meropenem—Sweating—Doxorubicin—uterine cancer	0.000872	0.000872	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—uterine cancer	0.00087	0.00087	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000861	0.000861	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—uterine cancer	0.000858	0.000858	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—uterine cancer	0.000849	0.000849	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—uterine cancer	0.000835	0.000835	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—uterine cancer	0.000832	0.000832	CcSEcCtD
Meropenem—Hypersensitivity—Etoposide—uterine cancer	0.000824	0.000824	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—uterine cancer	0.000821	0.000821	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—uterine cancer	0.000817	0.000817	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—uterine cancer	0.000817	0.000817	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—uterine cancer	0.000811	0.000811	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—uterine cancer	0.000805	0.000805	CcSEcCtD
Meropenem—Asthenia—Etoposide—uterine cancer	0.000803	0.000803	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—uterine cancer	0.000797	0.000797	CcSEcCtD
Meropenem—Chills—Epirubicin—uterine cancer	0.000792	0.000792	CcSEcCtD
Meropenem—Pruritus—Etoposide—uterine cancer	0.000792	0.000792	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—uterine cancer	0.000772	0.000772	CcSEcCtD
Meropenem—Erythema—Epirubicin—uterine cancer	0.000769	0.000769	CcSEcCtD
Meropenem—Diarrhoea—Etoposide—uterine cancer	0.000766	0.000766	CcSEcCtD
Meropenem—Flatulence—Epirubicin—uterine cancer	0.000757	0.000757	CcSEcCtD
Meropenem—Tension—Epirubicin—uterine cancer	0.000754	0.000754	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—uterine cancer	0.000753	0.000753	CcSEcCtD
Meropenem—Nervousness—Epirubicin—uterine cancer	0.000746	0.000746	CcSEcCtD
Meropenem—Back pain—Epirubicin—uterine cancer	0.000743	0.000743	CcSEcCtD
Meropenem—Dizziness—Etoposide—uterine cancer	0.00074	0.00074	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—uterine cancer	0.000738	0.000738	CcSEcCtD
Meropenem—Chills—Doxorubicin—uterine cancer	0.000733	0.000733	CcSEcCtD
Meropenem—Vomiting—Etoposide—uterine cancer	0.000711	0.000711	CcSEcCtD
Meropenem—Erythema—Doxorubicin—uterine cancer	0.000711	0.000711	CcSEcCtD
Meropenem—Anaemia—Epirubicin—uterine cancer	0.00071	0.00071	CcSEcCtD
Meropenem—Agitation—Epirubicin—uterine cancer	0.000706	0.000706	CcSEcCtD
Meropenem—Rash—Etoposide—uterine cancer	0.000706	0.000706	CcSEcCtD
Meropenem—Dermatitis—Etoposide—uterine cancer	0.000705	0.000705	CcSEcCtD
Meropenem—Headache—Etoposide—uterine cancer	0.000701	0.000701	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—uterine cancer	0.000701	0.000701	CcSEcCtD
Meropenem—Tension—Doxorubicin—uterine cancer	0.000698	0.000698	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—uterine cancer	0.000696	0.000696	CcSEcCtD
Meropenem—Malaise—Epirubicin—uterine cancer	0.000693	0.000693	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—uterine cancer	0.000691	0.000691	CcSEcCtD
Meropenem—Syncope—Epirubicin—uterine cancer	0.000689	0.000689	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—uterine cancer	0.000688	0.000688	CcSEcCtD
Meropenem—Back pain—Doxorubicin—uterine cancer	0.000688	0.000688	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—uterine cancer	0.000675	0.000675	CcSEcCtD
Meropenem—Cough—Epirubicin—uterine cancer	0.000671	0.000671	CcSEcCtD
Meropenem—Nausea—Etoposide—uterine cancer	0.000665	0.000665	CcSEcCtD
Meropenem—Hypertension—Epirubicin—uterine cancer	0.000664	0.000664	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—uterine cancer	0.000657	0.000657	CcSEcCtD
Meropenem—Chest pain—Epirubicin—uterine cancer	0.000654	0.000654	CcSEcCtD
Meropenem—Agitation—Doxorubicin—uterine cancer	0.000653	0.000653	CcSEcCtD
Meropenem—Anxiety—Epirubicin—uterine cancer	0.000652	0.000652	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00065	0.00065	CcSEcCtD
Meropenem—Malaise—Doxorubicin—uterine cancer	0.000641	0.000641	CcSEcCtD
Meropenem—Syncope—Doxorubicin—uterine cancer	0.000638	0.000638	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—uterine cancer	0.000637	0.000637	CcSEcCtD
Meropenem—Confusional state—Epirubicin—uterine cancer	0.000632	0.000632	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—uterine cancer	0.000627	0.000627	CcSEcCtD
Meropenem—Oedema—Epirubicin—uterine cancer	0.000627	0.000627	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—uterine cancer	0.000625	0.000625	CcSEcCtD
Meropenem—Infection—Epirubicin—uterine cancer	0.000623	0.000623	CcSEcCtD
Meropenem—Cough—Doxorubicin—uterine cancer	0.000621	0.000621	CcSEcCtD
Meropenem—Shock—Epirubicin—uterine cancer	0.000617	0.000617	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—uterine cancer	0.000615	0.000615	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—uterine cancer	0.000614	0.000614	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—uterine cancer	0.000614	0.000614	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—uterine cancer	0.000612	0.000612	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—uterine cancer	0.000609	0.000609	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—uterine cancer	0.000606	0.000606	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—uterine cancer	0.000605	0.000605	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—uterine cancer	0.000603	0.000603	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000601	0.000601	CcSEcCtD
Meropenem—Anorexia—Epirubicin—uterine cancer	0.000598	0.000598	CcSEcCtD
Meropenem—Hypotension—Epirubicin—uterine cancer	0.000586	0.000586	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—uterine cancer	0.000585	0.000585	CcSEcCtD
Meropenem—Oedema—Doxorubicin—uterine cancer	0.00058	0.00058	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—uterine cancer	0.00058	0.00058	CcSEcCtD
Meropenem—Infection—Doxorubicin—uterine cancer	0.000577	0.000577	CcSEcCtD
Meropenem—Shock—Doxorubicin—uterine cancer	0.000571	0.000571	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—uterine cancer	0.000569	0.000569	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—uterine cancer	0.000568	0.000568	CcSEcCtD
Meropenem—Insomnia—Epirubicin—uterine cancer	0.000567	0.000567	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—uterine cancer	0.000566	0.000566	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—uterine cancer	0.000564	0.000564	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—uterine cancer	0.000563	0.000563	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—uterine cancer	0.000561	0.000561	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—uterine cancer	0.000559	0.000559	CcSEcCtD
Meropenem—Somnolence—Epirubicin—uterine cancer	0.000558	0.000558	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—uterine cancer	0.000553	0.000553	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—uterine cancer	0.000552	0.000552	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—uterine cancer	0.000545	0.000545	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—uterine cancer	0.000542	0.000542	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000541	0.000541	CcSEcCtD
Meropenem—Constipation—Epirubicin—uterine cancer	0.000536	0.000536	CcSEcCtD
Meropenem—Pain—Epirubicin—uterine cancer	0.000536	0.000536	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—uterine cancer	0.000525	0.000525	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—uterine cancer	0.000521	0.000521	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—uterine cancer	0.000517	0.000517	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—uterine cancer	0.000517	0.000517	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—uterine cancer	0.000516	0.000516	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—uterine cancer	0.000513	0.000513	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—uterine cancer	0.000511	0.000511	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—uterine cancer	0.000504	0.000504	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000501	0.000501	CcSEcCtD
Meropenem—Urticaria—Epirubicin—uterine cancer	0.000498	0.000498	CcSEcCtD
Meropenem—Constipation—Doxorubicin—uterine cancer	0.000496	0.000496	CcSEcCtD
Meropenem—Pain—Doxorubicin—uterine cancer	0.000496	0.000496	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—uterine cancer	0.000496	0.000496	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—uterine cancer	0.000496	0.000496	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—uterine cancer	0.000478	0.000478	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000475	0.000475	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—uterine cancer	0.000462	0.000462	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—uterine cancer	0.000461	0.000461	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—uterine cancer	0.000459	0.000459	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—uterine cancer	0.000459	0.000459	CcSEcCtD
Meropenem—Asthenia—Epirubicin—uterine cancer	0.00045	0.00045	CcSEcCtD
Meropenem—Pruritus—Epirubicin—uterine cancer	0.000444	0.000444	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—uterine cancer	0.000429	0.000429	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—uterine cancer	0.000428	0.000428	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—uterine cancer	0.000416	0.000416	CcSEcCtD
Meropenem—Dizziness—Epirubicin—uterine cancer	0.000415	0.000415	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—uterine cancer	0.000411	0.000411	CcSEcCtD
Meropenem—Vomiting—Epirubicin—uterine cancer	0.000399	0.000399	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—uterine cancer	0.000397	0.000397	CcSEcCtD
Meropenem—Rash—Epirubicin—uterine cancer	0.000395	0.000395	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—uterine cancer	0.000395	0.000395	CcSEcCtD
Meropenem—Headache—Epirubicin—uterine cancer	0.000393	0.000393	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—uterine cancer	0.000384	0.000384	CcSEcCtD
Meropenem—Nausea—Epirubicin—uterine cancer	0.000373	0.000373	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—uterine cancer	0.000369	0.000369	CcSEcCtD
Meropenem—Rash—Doxorubicin—uterine cancer	0.000366	0.000366	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—uterine cancer	0.000366	0.000366	CcSEcCtD
Meropenem—Headache—Doxorubicin—uterine cancer	0.000364	0.000364	CcSEcCtD
Meropenem—Nausea—Doxorubicin—uterine cancer	0.000345	0.000345	CcSEcCtD
